He. Mcdowell et al., Regulation of System A amino acid transport in L6 rat skeletal muscle cells by insulin, chemical and hyperthermic stress, FEBS LETTER, 441(1), 1998, pp. 15-19
In this study we have investigated the effects of insulin, chemical and hyp
erthermic stresses upon the activity of the System A amino acid transporter
in L6 rat muscle cells. Uptake of a-methyl-aminoisobutyric acid (Me-AIB),
a non-metabolisable System A substrate, was increased by between 50% and 80
% when muscle cells mere exposed to a maximally effective concentration of
insulin (100 nM), sodium arsenite (ARS, 0.5 mM) or a 42 degrees C heat shoc
k (HS). The observed activation in System A in response to all three stimul
i was maximal within 20 min and in the case of insulin and ARS primarily in
volved an increase in the V-max of System A transport. In contrast, HS indu
ced significant increases in both V-max and K-m of System A transport sugge
sting that hyperthermic stress may activate System A by a mechanism distinc
t from that mediating the effects of insulin and ARS. The hormonal stimulat
ion of System A was blocked by the phosphoinositide 3-kinase (PI3k) inhibit
or, wortmannin, but not by rapamycin or PD 98059 which respectively inhibit
the mTOR and classical MAP kinase pathways. Exposure of L6 cells to ARS, b
ut not HS, caused a 4.7-fold stimulation in MAPKAP-K2 activity that was blo
cked by SE 203580, a specific inhibitor of the stress activated protein kin
ase SAPK2/p38. However, neither SE 203580, rapamycin nor wortmannin were ab
le to suppress the ARS- or HS-induced stimulation in System A transport, In
summary, our results demonstrate that activity of the System A transporter
can be rapidly upregulated in response to hormonal and stress stimuli thro
ugh changes in the transport kinetics of the System A carrier, Our data sho
w that whilst the hormonal response is PI3k dependent, the signalling mecha
nisms which instigate changes in System A activity in response to chemical
or hyperthermic stress do not appear to involve PI3k or components of the m
TOR, p42/p44 MAP kinase or SAPK2/p38 signalling pathways. (C) 1998 Federati
on of European Biochemical Societies.